Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:40 AM
Ignite Modification Date:
2025-12-25 @ 1:40 AM
NCT ID:
NCT00900094
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Meets 1 of the following criteria (patient):
* Scheduled to undergo primary surgical resection or first debulking surgery (prior to any anticancer treatment) for suspected or newly diagnosed cancer, including any of the following types:
* Breast cancer
* Adenocarcinoma of the colon
* Adenocarcinoma or squamous cell carcinoma of the esophagus
* Non-small cell lung cancer
* Ovarian epithelial adenocarcinoma
* Metastatic or unresectable cancer, including any of the following types:
* Breast cancer
* Adenocarcinoma of the colon
* Adenocarcinoma or squamous cell carcinoma of the esophagus
* Hepatoma
* Non-small cell lung cancer
* Small cell lung cancer
* Ovarian epithelial adenocarcinoma
* Adenocarcinoma of the pancreas
* Meets the following criteria (healthy participant):
* No chronic disease
* Healthy participants with a history of cancer must be cancer-free for 5 years (skin cancer or carcinoma in situ of the cervix within the past 5 years allowed)
* Willing to provide 60 mL of blood
* Not a blood relative of an eligible and consenting cancer patient
PATIENT CHARACTERISTICS:
* Able to tolerate the removal of 30-60 mL of blood
* No feelings of light-headedness, dizziness, or fainting within the past 2 weeks
* Pulse less than 100 on day of blood draw for study enrollment
PRIOR CONCURRENT THERAPY:
* See Disease Characteristics
* At least 3 weeks since prior chemotherapy or radiotherapy for metastatic or unresectable cancer
* No concurrent chemotherapy
* No concurrent radiotherapy
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00900094
Study Brief:
Protocol Section:
NCT00900094